Laboratorios Farmacéuticos Rovi, S.A.

Laboratorios Farmacéuticos Rovi, S.A. is a Spanish specialty pharmaceutical company that focuses on the research, development, manufacturing, and marketing of pharmaceutical products. Its core areas of expertise include small molecule drugs and specialty biologics, with a notable emphasis on heparin-derived products such as Bemiparin and enoxaparin biosimilars. Rovi's diversified portfolio spans prescription and hospital medicines, covering therapeutic fields like cardiology, neurology, endocrinology, respiratory health, diagnostic imaging, urology, and primary healthcare. The company also leads contract manufacturing for injectable and solid formulations, serving as a vertically integrated provider with FDA- and GMP-certified plants capable of significant production volumes for prefilled syringes, vials, tablets, and other forms. Rovi plays an important role in supplying high-quality pharmaceuticals and contract development and manufacturing services (CDMO) across more than 60 countries, strengthening healthcare infrastructure and supporting chronic as well as acute medical needs. Since its founding in 1946, Rovi has built a reputation for its innovation in anticoagulant therapies and medical devices while supporting partner companies through end-to-end pharmaceutical manufacturing solutions.